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ABSTRACT 
The present study was designed to evaluate the hypoglycemic effect of 
Nigella sativa (Black cumin) seeds and to explore how the induction of 
hypoglycemia، by feeding seeds، can modulate glucose metabolism in 
animals. This effect was compared with a reference of a known 
hypoglycemic drug Glibenclamide. 
Thirty female Wister albino rats were used as experimental animals and 
divided into five groups (A، B، C، D and E) of six rats each. Each rat was 
fed 8 g for 30 days as follows:  In group A، the rats were fed basal diet 
and kept as control ، group B was fed Glibenclamide (hypoglycemic 
drug) at the rate of 10 mg/kg body weight، calculated as part from the rat 
basal diet، group C was fed Nigella sativa (50 mg/day as part from the 
basal diet)،  group D was fed Nigella sativa (50 mg/day + glucose 2g/kg 
body weight as part from the basal diet) and group E was fed glucose 
(2g/kg body weight calculated as part from the rat basal diet). Blood 
glucose levels were measured weekly. Insulin concentration was 
recorded at days 14 and 28. At the end of the experimental period، blood 
hemoglobin concentration was measured and oral glucose tolerance test 
was conducted for all rats. Glucose-6-phosphate dehydrogenase and 
Alanine aminotrasferase activities were estimated، and a 
histophathological examination of the liver and the pancreas was done 
for all groups. Animal's body weight was reported at the beginning and at 
the end of the experiment.    
x 
 
All the treated groups showed significant reduction in blood glucose 
concentration after one week of treatment، and it was more pronounced 
in group B. At the second week and until the end of the experiment، 
significant reduction compared to the control group، were maintained 
only in groups B and C which received Glibenclamide and N. sativa، 
respectively. By the end of the experiment، groups D and E showed 
similar levels of glucose to the control group. In group D، feeding high 
glucose dose was not associated with the application of N. sativa to the 
diet. When insulin concentration was measured after two weeks، no 
significant increase was observed in all groups except groups D and E. 
By the end of the experimental period، all treated groups showed 
significantly higher insulin levels and it was significantly higher in group 
E. 
After four weeks of treatment، no significant changes were noticed in 
Glucose-6-phosphate dehydrogenase activity in all groups، only higher 
values were found in groups D and E، being two folds higher than group 
B. The activity of Alanine aminotrasferase was significantly increased in 
the group receiving N. sativa but was significantly decreased in the 
groups treated with Glibenclamide and glucose، respectively. The 
performance of the groups receiving Glibenclamide or only the N. sativa 
was similar، when Glucose Tolerance Test was carried out، but addition 
of extra glucose to the rat basal diet plus the N. sativa abolished this 
effect. Hemoglobin concentration and animal’s body weight were not 
influenced by all treatments applied. No histopathological changes were 
xi 
 
noticed in the liver and pancreas of Nigella sativa treated groups 
compared with the other groups and the control. 
The results showed that Nigella sativa at 50 mg/day can exerts potential 
hypoglycemic effects in rats. The hypoglycemic effect of the seeds may 
be mediated، at least in part، by decreasing glucose concentration and 
increasing insulin level. Glucose uptake and absorption were 
significantly influenced by feeding N. sativa to the rats. The increase of 
Alanine aminotrasferase activity in N. sativa treated groups، with no 
histopathological changes، may indicate slight effects on the integrity of 
liver cells. 
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 اﻟﻤﺴﺘﺨﻠﺺ
ﻓﻰ ﺧﻔﺾ ﺳﻜﺮ اﻟﺪم، وﻟﺘﻮﺿﻴﺢ آﻴﻔﻴﺔ ( اﻟﺤﺒﺔ اﻟﺴﻮداء)ﺻﻤﻤﺖ اﻟﺪراﺳﺔ اﻟﺤﺎﻟﻴﺔ ﻟﺘﻘﻴﻴﻢ ﺗﺄﺛﻴﺮاﻟﻜﻤﻮن 
اﻟﺒﺬور، وﻣﻘﺎرﻧﺔ هﺬا إﺣﺪاث ﺧﻔﺾ ﺳﻜﺮ اﻟﺪم ﺑﺘﻐﻴﻴﺮ أﻳﺾ اﻟﺠﻠﻜﻮز ﻓﻰ اﻟﺤﻴﻮاﻧﺎت اﻟﺘﻰ أﻋﻄﻴﺖ 
  .اﻟﺘﺄﺛﻴﺮ ﺑﺪواء اﻟﺠﻠﺒﻨﻜﻼﻣﻴﺪ اﻟﻤﻌﺮوف ﺑﺨﻔﻀﻪ ﻟﺴﻜﺮ اﻟﺪم
أ، ب، )أﻧﺜﻰ ﺟﺮذ وﺳﺘﺮ أﻟﺒﻴﻨﻮ آﺤﻴﻮاﻧﺎت ﺗﺠﺎرب وﻗﺴﻤﺖ إﻟﻰ ﺧﻤﺲ ﻣﺠﻤﻮﻋﺎت  03إﺳﺘﺨﺪﻣﺖ 
أﻃﻌﻤﺖ اﻟﺠﺮذان ﻓﻰ : ﻳﻮﻣﺎ آﺎﻷﺗﻰ 03ﺟﺮام ﻟﻤﺪة  8أﻃﻌﻢ آﻞ ﺟﺮذ . ﺟﺮذان ﻟﻜٍﻞ 6( ج، د، هـ
ﺳﺘﺨﺪﻣﺖ آﻤﺠﻤﻮﻋﺔ ﺷﺎهﺪ، وأﻋﻄﻴﺖ اﻟﻤﺠﻤﻮﻋﺔ ب اﻟﺠﻠﺒﻨﻜﻼﻣﻴﺪ اﻟﻤﺠﻤﻮﻋﺔ أ اﻷآﻞ اﻷﺳﺎﺳﻰ وإ
ﺣﺴﺒﺖ آﺠﺰء ﻣﻦ اﻷآﻞ )آﺠﻢ ﻣﻦ وزن اﻟﺠﺴﻢ /ﻣﻠﺠﺮام 01ﺑﺠﺮﻋﻪ ( دواء ﺧﺎﻓﺾ ﻟﺴﻜﺮ اﻟﺪم)
اﻟﻴﻮم آﺠﺰء ﻣﻦ اﻷآﻞ اﻷﺳﺎﺳﻰ، /ﻣﻠﺠﺮام 05، وأﻋﻄﻴﺖ اﻟﻤﺠﻤﻮﻋﺔ ج اﻟﻜﻤﻮن ﺑﻤﻌﺪل (اﻷﺳﺎﺳﻰ
آﺠﻢ ﻣﻦ /ﺟﺮام2)ﺎﻓﺔ إﻟﻰ اﻟﺠﻠﻜﻮز اﻟﻴﻮم إﺿ/ﻣﻠﺠﺮام 05وأﻋﻄﻴﺖ اﻟﻤﺠﻤﻮﻋﺔ د اﻟﻜﻤﻮن ﺑﻤﻌﺪل 
آﺠﻢ ﻣﻦ وزن /ﺟﺮام2)، وأﻋﻄﻴﺖ اﻟﻤﺠﻤﻮﻋﺔ هـ اﻟﺠﻠﻜﻮز (وزن اﻟﺠﺴﻢ آﺠﺰء ﻣﻦ اﻷآﻞ اﻷﺳﺎﺳﻰ
ﺳﺠﻞ ﻣﺴﺘﻮى ﺟﻠﻜﻮز اﻟﺪم إﺳﺒﻮﻋﻴًﺎ و ﺗﺮآﻴﺰ (. اﻟﺠﺴﻢ وﺗﻢ ﺣﺴﺎﺑﻬﺎ آﺠﺰء ﻣﻦ اﻷآﻞ اﻷﺳﺎﺳﻰ
ﻤﻮﻏﻠﻮﺑﻴﻦ اﻟﺪم و ﻓﻰ ﻧﻬﺎﻳﺔ ﻣﺪة اﻟﺘﺠﺮﺑﺔ ﺳﺠﻞ ﺗﺮآﻴﺰ هﻴ.  82و  41هﺮﻣﻮن اﻹﻧﺴﻮﻟﻴﻦ ﻓﻰ اﻟﻴﻮم 
ﻓﻮﺳﻔﻴﺖ -6-ﺗﻢ ﺗﻘﺪﻳﺮ ﻧﺸﺎط إﻧﺰﻳﻢ اﻟﺠﻠﻜﻮز. إﺟﺮى إﺧﺘﺒﺎر ﺗﺤﻤﻞ اﻟﺠﻠﻜﻮز ﻟﻜﻞ اﻟﺠﺮذان
ﻟﻜﻞ  دﻳﻬﻴﺪروﺟﻴﻨﻴﺰ واﻷﻟﻨﻴﻦ أﻣﻴﻨﻮﺗﺮاﻧﺴﻔﻴﺮﻳﺰ، آﻤﺎ ﻓﺤﺼﺖ اﻷﻧﺴﺠﺔ اﻟﻤﺮﺿﻴﺔ ﻟﻠﻜﺒﺪ واﻟﺒﻨﻜﺮﻳﺎس
  .اﻟﻤﺠﻤﻮﻋﺎت وﺳﺠﻠﺖ أوزان اﻟﺤﻴﻮاﻧﺎت ﻓﻰ ﺑﺪاﻳﺔ وﻧﻬﺎﻳﺔ اﻟﺘﺠﺮﺑﺔ
ﺎﻟﺠﺔ ﻧﻘﺼًﺎ ﻣﻌﻨﻮﻳًﺎ ﻓﻰ ﺗﺮآﻴﺰ ﺟﻠﻜﻮز اﻟﺪم ﺑﻌﺪ إﺳﺒﻮع ﻣﻦ اﻟﺘﺠﺮﺑﺔ أﻇﻬﺮت آﻞ اﻟﻤﺠﻤﻮﻋﺎت اﻟﻤﻌ
اﻟﻤﺠﻤﻮﻋﺔ )وآﺎن هﻨﺎﻟﻚ إﻧﺨﻔﺎﺿًﺎ ﻓﻰ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ ب و ج . وآﺎن أآﺜﺮ وﺿﻮﺣًﺎ ﻓﻰ اﻟﻤﺠﻤﻮﻋﺔ ب
ﻓﻰ اﻷﺳﺒﻮع اﻟﺜﺎﻧﻰ وﺣﺘﻰ ( اﻟﻤﻌﺎﻟﺠﺔ ﺑﺎﻟﺠﻠﺒﻨﻜﻼﻣﻴﺪ واﻟﻤﺠﻤﻮﻋﺔ اﻟﻤﻌﺎﻟﺠﺔ ﺑﺎﻟﻜﻤﻮن ﻋﻠﻰ اﻟﺘﻮاﻟﻰ
ﺑﻨﻬﺎﻳﺔ اﻟﺘﺠﺮﺑﺔ أﻇﻬﺮت ﻣﺠﻤﻮﻋﺘﻰ اﻹﺧﺘﺒﺎر د و هـ . ﻋﺔ اﻟﺸﺎهﺪﻧﻬﺎﻳﺔ اﻟﺘﺠﺮﺑﺔ ﻣﻘﺎرﻧﺔ ﻣﻊ ﻣﺠﻤﻮ
إﻋﻄﺎء ﺟﺮﻋﺔ ﻋﺎﻟﻴﺔ ﻣﻦ اﻟﺠﻠﻜﻮز ﻟﻠﻤﺠﻤﻮﻋﺔ د ﻏﻴﺮ . ﻣﺴﺘﻮﻳﺎت ﺟﻠﻜﻮز ﻣﺸﺎﺑﻬﺔ ﻟﻤﺠﻤﻮﻋﺔ اﻟﺸﺎهﺪ
ﺑﻨﻬﺎﻳﺔ ﻣﺪة . ﻣﺼﺎﺣﺒﺔ ﺑﺈﻋﻄﺎء اﻟﻜﻤﻮن ﻣﻌﻨﻮﻳﻪ ﻓﻰ آﻞ اﻟﻤﺠﻤﻮﻋﺎت ﻋﺪا اﻟﻤﺠﻤﻮﻋﺘﻴﻦ د و هـ
هﺮﻣﻮن اﻹﻧﺴﻮﻟﻴﻦ وﺑﺰﻳﺎدًة أآﺒﺮ ﻓﻰ  اﻟﻤﻌﺎﻟﺠﺔ أﻇﻬﺮت آﻞ اﻟﻤﺠﻤﻮﻋﺎت زﻳﺎدة ﻓﻰ ﻣﺴﺘﻮى
  .اﻟﻤﺠﻤﻮﻋﺔ هـ
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ﻓﻮﺳﻔﻴﺖ دﻳﻬﻴﺪروﺟﻴﻨﻴﺰ ﻓﻰ آﻞ -6-ﻟﻢ ﺗﻼﺣﻆ أى ﺗﻐﻴﺮات ﻣﻌﻨﻮﻳﻪ ﻓﻰ ﻧﺸﺎط إﻧﺰﻳﻢ اﻟﺠﻠﻜﻮز
اﻟﻤﺠﻤﻮﻋﺎت ﺑﻌﺪ أرﺑﻌﺔ أﺳﺎﺑﻴﻊ ﻣﻦ اﻟﻤﻌﺎﻟﺠﺔ، وﻗﺪ ﻟﻮﺣﻈﺖ اﻟﺰﻳﺎدات ﻓﻘﻂ ﻓﻰ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ د و هـ 
ﻧﺸﺎط إﻧﺰﻳﻢ اﻷﻟﻨﻴﻦ أﻣﻴﻨﻮﺗﺮاﻧﺴﻔﻴﺮﻳﺰ ﺣﺪﺛﺖ زﻳﺎدة ﻣﻌﻨﻮﻳﻪ ﻓﻰ .  اﻟﺘﻰ ﺑﻠﻐﺖ ﺿﻌﻒ  اﻟﻤﺠﻤﻮﻋﺔ ب
ﻓﻰ اﻟﻤﺠﻤﻮﻋﺔ اﻟﺘﻰ أﻋﻄﻴﺖ اﻟﻜﻤﻮن ﺑﻴﻨﻤﺎ ﻟﻮﺣﻆ ﻧﻘﺺ ﻣﻌﻨﻮى ﻓﻰ اﻟﻤﺠﻤﻮﻋﺎت اﻟﻤﻌﺎﻟﺠﺔ 
ﻋﻨﺪ إﺟﺮاء إﺧﺘﺒﺎر ﺗﺤﻤﻞ اﻟﺠﻠﻜﻮز آﺎن اﻷداء ﻣﺘﺴﺎوى ﻓﻰ . ﺑﺎﻟﺠﻠﺒﻨﻜﻼﻣﻴﺪ واﻟﺠﻠﻜﻮز ﻋﻠﻰ اﻟﺘﻮاﻟﻰ
ﻠﻜﻮز ﻷآﻞ اﻟﺠﺮذان اﻟﻤﺠﻤﻮﻋﺎت اﻟﺘﻰ أﻋﻄﻴﺖ اﻟﺠﻠﺒﻨﻜﻼﻣﻴﺪ واﻟﻜﻤﻮن ﻓﻘﻂ ، ﻟﻜﻦ إﺿﺎﻓﺔ اﻟﺠ
ﻟﻢ ﻳﺘﺄﺛﺮ ﺗﺮآﻴﺰ اﻟﻬﻴﻤﻮﻏﻠﻮﺑﻴﻦ وأوزان اﻟﺤﻴﻮاﻧﺎت . اﻷﺳﺎﺳﻰ ﺑﺎﻹﺿﺎﻓﺔ ﻟﻠﻜﻤﻮن اﻟﻐﻰ هﺬا اﻟﺘﺄﺛﻴﺮ
ﻟﻢ ﺗﻼﺣﻆ أى ﺗﻐﻴﺮات أﻧﺴﺠﺔ ﻣﺮﺿﻴﺔ ﻓﻰ اﻟﻜﺒﺪ واﻟﺒﻨﻜﺮﻳﺎس  ﻟﻠﻤﺠﻤﻮﻋﺎت اﻟﻤﻌﺎﻟﺠﺔ . ﺑﺎﻟﻤﻌﺎﻣﻼت
  .ﺑﺎﻟﻜﻤﻮن ﻣﻘﺎرﻧﺔ ﺑﺎﻟﻤﺠﻤﻮﻋﺎت اﻷﺧﺮى وﻣﺠﻤﻮﻋﺔ اﻟﺸﺎهﺪ
. اﻟﻴﻮم ﻗﺪ ﻳﻈﻬﺮ ﺗﺄﺛﻴﺮًا ﺑﺨﻔﺾ ﺳﻜﺮ اﻟﺪم ﻓﻰ اﻟﺠﺮذان/ﻣﻠﺠﺮام05ﻜﻤﻮن ﺑﻤﻌﺪل أﻇﻬﺮت اﻟﻨﺘﺎﺋﺞ أن اﻟ
وﻗﺪ ﻳﻜﻮن ﺗﺄﺛﻴﺮ اﻟﺒﺬور اﻟﺨﺎﻓﺾ ﻟﺴﻜﺮ اﻟﺪم ، ﻋﻠﻰ اﻷﻗﻞ ﺟﺰﺋﻴًﺎ، ﺑﺨﻔﺾ ﺗﺮآﻴﺰ اﻟﺠﻠﻜﻮز وزﻳﺎدة  
وهﻨﺎﻟﻚ ﺗﺄﺛﻴﺮ ﻣﻌﻨﻮى ﻹﻋﻄﺎء اﻟﻜﻤﻮن ﻋﻠﻰ إﺳﺘﻬﻼك وإﻣﺘﺼﺎص . ﻣﺴﺘﻮى هﺮﻣﻮن اﻹﻧﺴﻮﻟﻴﻦ
ﻧﺸﺎط إﻧﺰﻳﻢ اﻷﻟﻨﻴﻦ اﻣﻴﻨﻮﺗﺮاﻧﺴﻔﻴﺮﻳﺰ ﻓﻰ اﻟﻤﺠﻤﻮﻋﺎت اﻟﻤﻌﺎﻟﺠﺔ زﻳﺎدة . اﻟﺠﻠﻜﻮز ﻓﻰ اﻟﺠﺮذان
ﺧﻼﻳﺎ  ﺑﺎﻟﻜﻤﻮن، ﻣﻊ ﻋﺪم وﺟﻮد ﺗﻐﻴﺮات أﻧﺴﺠﺔ ﻣﺮﺿﻴﺔ، ﻗﺪ ﻳﺪل ﻋﻠﻰ اﻟﺘﺄﺛﻴﺮ اﻟﻄﻔﻴﻒ ﻋﻠﻰ ﺳﻼﻣﺔ
  .اﻟﻜﺒﺪ
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INTRODUCTION 
Diabetes Mellitus is a serious, complex metabolic disorder of multiple etiologies. It 
has a significant impact on the health, quality of life and life expectancy of patients, 
as well as on the health care system (Kwon et al., 2008). Although different types 
of hypoglycaemic agents such as thiazolidinediones, insulin, biguanides and 
sulphunylurea are available, but there is growing interest in herbal remedies due to 
the side effects associated with these therapeutic agents, beside their limitations in 
managing the disease effectively. Diabetes Mellitus characterized by chronic 
hyperglycemia with disturbances of carbohydrate, fat and protein metabolism 
resulting from defects in insulin secretion (B-cell dysfunction), insulin action 
(insulin resistant) or both (Kardesler et al., 2008). 
Type 2 insulin-resistant diabetes mellitus accounts for 90-95% of all diabetes. Both 
genetic and environmental factors play an important role in the onset of type 2 
insulin-resistant diabetes (Lima et al., 2008). The microvascular and macrovascular 
complications of diabetes including cardiovascular disease, blind-ness, renal failure 
and peripheral nerve damage (Taskinen, 2002). Recent estimates indicate there 
were 171 million people in the world with diabetes in the year 2000 and this is 
projected to increase to 366 million by 2030 (Wild et al., 2004). Around 3.2 million 
deaths every year are related to a complication of diabetes, which equals six deaths 
each minute (WHO, 2007). 
Renewed attention to alternative medicine and natural therapies has stimulated new 
researches to look for more efficacious agents with lesser side effects (Kim et al., 
2006). According to the world ethno botanical information reports, almost 800 
plants may possess antidiabetic potential. N. sativa is one such herbal product 
which has been in use as a spice from ancient times. Its medicinal value to treat 
various ailments is also well-known (Khanam and Dewan, 2008). N. sativa and 
several species of plants have been described as having antidiabetic property 
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(Uddin et al., 2002; Uddin et al., 2005). Naturally occurring antidiabetic plant are 
relatively non toxic, inexpensive and available in an ingestive form. It used where 
low and middle-income populations are important (Gazioano et al., 2007). 
The objectives of the present study are to investigate about the hypoglycemic effect 
of N. sativa seeds on glucose absorption uptake and metabolism in Wister albino 
female rats. The effects of feeding the seeds will be compared to the effect of the 
Glibenclamide (hypoglycemic drug). The parameters to be measured include: 
? Plasma glucose concentration. 
? Serum insulin concentration. 
? Glucose-6-phosphate dehydrogenase activity. 
?  Blood Hemoglobin (Hb). 
? To perform oral glucose tolerance test (OGTT). 
?  To measure Alanine aminotransferase (ALT) activity. 
?  To measure changes in animal’s body weight. 
?  To examine histopathological changes related to treatments  
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CHAPTER ONE 
LITERATURE REVIEW 
 
1.1 Nigella sativa 
Nigella sativa (N. sativa) commonly known as black seed or black cumin is a small 
plant originating in the Middle East and is found widely in Egypt, Asiatic Turkey 
and the Balkan states. It has been traditionally used in the Indian subcontinent 
(Nadkarni, 1976), Arabian countries (Sayed, 1980) and Europe (Lautenbacher, 
1997) for culinary and medicinal purposes as a natural remedy for number of 
illnesses and conditions. 
Abu Huraira (may God be pleased with him) narrated that God’s Messenger (pbuh) 
said, “Use this black seed regularly because it contains a cure for every disease 
except death.” N. sativa seeds are claimed to have bronchodilatory, hypotensive, 
antibacterial, antifungal, analgesic, anti-inflammatory and immunopotentiating 
properties (Schmall, 2007).The seed extracts from this plant are used in traditional 
medicine (Hakims or tabibs) in the treatment of several medical disorders including 
dyslipidemia, obesity and hypertension (Le et al,.2004). 
Nigella sativa seed is herbaceous annual plant belonging to the Ranunculaceae 
family; it is cultivated in several countries in the Mediterranean region and Asia. In 
South Asia, it is called kalonji, its Arabic name is habbat el Baraka or habbah 
saouda and in English it is known as black cumin. The seeds of N. sativa have been 
employed for thousands years as a spice and food preservative (Aboutabl et al., 
1986; Hanafy and Hatem, 1991). Additionally, it used in the traditional medicine 
applications (Abdulelah and Zainal-Abidin, 2007). 
The seeds of Nigella sativa (N. sativa) has been showed to contain >30% of fixed 
oil and 0.4 – 0.45% wt/wt of volatile oil, protein, alkaloid, flavonoid and saponins 
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(Winkler et al., 2005). The volatile oil has been showed to contain 18.4 – 24% 
thymoquinone (2-isopropyl-5-methyl-1, 4-benzoquinone) and 46% monoterpenes 
such as p-cymene and &-piene (El-Tahair et al., 1993). The biological activity of 
the seeds has been showed to be due to thymoquinone, which is also present in the 
fixed oil (Ghosheh et al., 1999). 
N. sativa has been known for it is hypotensive (El-Tahir et al., 1993), exhibited 
hepatoprotective effect against liver damage (Al-Gharably et al., 1997; Nagi et al., 
1999; El-Dakhakhny et al., 2002), antimicrobial (El-Alfy et al.,1975), antibacterial 
(El-Kamali et al.,1998), antioxidant (Burits and Mucar,2000), anti-inflammatory 
(Houghton et al.,1995) and antitumoral (Worthen et al.,1998). Besides, the 
essential oil was showed to have anthelmentic activity (Agarwal et al., 1979) and 
the seeds were effective against cestodes and nematodes (Akhtar and Rifaat, 1991).  
N. sativa seeds have also been reported to have hypoglycemic activities (Al-Hader 
et al., 1993; El-Dakhakhny et al., 2002), which are principally related to the lipidic 
compounds of the seeds. 
1.1.1 Scientific classification 
Kingdom:  Plantae 
Division: Magnoliophyta 
Class: Magnoliopsida 
Order: Ranunculales  
Family: Ranunculaceae 
Genus: Nigella 
Species: N. sativa 
Binomial name: Nigella sativa L. 
1.1.2 Botanical description 
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N. sativa is an annual herb 35-50 cm tall, branching at the top, stems green, round, 
hairy, 2-5 mm diameter, internodes 2-5 cm long, flowers regular bisexual terminal 
on branches, white or greenish white about 3 cm diameter, long stalked, pedicels 
1.5-5.5 cm long, becoming longer as the fruit matures (El-Dakhakhny et al., 2000). 
N. sativa reproduces with itself and forms a fruit capsule which consists of many 
white trigonal seeds. Once the fruit capsule has matured, it opens up and the seeds 
contained within are exposed to the air, becoming black in color (Schleicher and 
Saleh, 1998). 
1.1.3 Chemical composition 
The multiple uses of N. sativa seeds in the folk medicine encouraged many 
researches to identification and isolation to the major constituent of it and to 
understand the pharmacological action. The seeds of N. sativa are the source of the 
active ingredients of this plant (thymoquinone). The oil and seed constituents have 
showed potential medicinal properties in traditional medicine (Salem, 2005). N. 
Sativa seeds contain 36%-38% fixed oils, proteins, alkaloids, saponins and 0.4%-
2.5% essential oil (Lautenbacher, 1997).  
The fixed oil is composed mainly of unsaturated fatty acids, including the unusual 
C20:2 arachidic and eicosadienoic acids (Houghton et al., 1995). The essential oil 
was analyzed by Burits and Bucar (2000). Many components were characterized, 
but the major ones were thymoquinone (27.8%- 57.0%), ñ-cymene (7.1%-15.5%), 
carvacrol (5.8%-11.6%), t-anethole (0.25%-2.3%), 4-terpineol (2.0%-6.6%) and 
longifoline (1.0%-8.0%). Thymoquinone readily dimerizes to form 
dithymoquinone (El-Dakhakhny, 1965). Four alkaloids have been reported as 
constituents of N. sativa seeds. Two, nigellicine and nigellidine have an indazole 
nucleus, whereas nigellimine and its N-oxide are isoquinolines (Atta-ur-Rahman et 
al., 1985; 1992; 1995). 
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In spite of there were no lead, cadmium and arsenic were found in the seeds. Zinc, 
calcium, magnesium, manganese and copper were found at lower level while 
potassium, phosphorus, sodium and iron are predominant elements. Linoleic and 
oleic acids were the major unsaturated fatty acids while palmitic acid was the main 
saturated one. Glutamic acid, arginine and aspartic acid were the main amino acids 
present while cystine and methionine were the minor amino acids (Al-Jassir, 1992).    
1.1.4 Distribution 
N. sativa is native to southwest Asia, also it grows in Mediterranean countries and 
it is also cultivated in the south of Algerian (Winkler et al., 2005). It is also found 
in southern Europe and northern Africa.  
1.1.5 Pharmacological properties 
This plant has been a focus of much research, particularly during the past two 
decades. It has several traditional uses and consequently has been extensively 
studied for its chemical constituents and biological activities on various body 
systems in vivo or in vitro. A lot of animal studies have already been done to 
identify the various activities of N. sativa oil on different components of the 
metabolic syndrome, for example blood glucose (Bamosa, 1997).  
The N. sativa seeds, seeds extract and thymoquinone have long been used in the 
Middle and Far East as a traditional medicine for a wide range of illnesses 
including bronchial asthma, headache, dysentery, infections, obesity, back pain, 
hypertension and gastrointestinal problems (Schleicher and Saleh, 1998; Al-
Rowais, 2002). Until now it have antihypertensive (Rashid et al., 1987), 
antibacterial (Hanafy and Hatem, 1991; Morsi, 2000), antiviral (Salem and 
Hossain, 2000), antidiabetic (Uddin et al., 2002; Uddin et al., 2005) and lipid 
lowering (Shaha et al., 2004). Renoprotective (Ragheb et al., 2009) potentialities 
have been obtained through research.  
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Various therapeutic effects, such as antiepileptic effects in children with refractory 
seizures (Akhondian et al., 2007), anti-inflammatory and analgesic actions (Khanna 
et al., 1993; Mutabagani and El-Mahdi, 1997; Abdel-Fattah et al., 2000) and 
antihistaminic (El-Dakhakhny et al., 2000; Kanter, 2006) have been described for 
N. sativa. Additionally, it has been shown that N. sativa has protective effect 
against ischemia reperfusion injury to liver and various organs (El-Abhar et al., 
2003). Its use in skin condition as eczema has also been recognized worldwide 
(Goreja, 2003). 
Besides these effects, N. sativa also demonstrates anti- parasitic effects. For 
instance, its administration decreases the number of eggs as well as worms in 
schistosomiasis, which tends to affect hepatic and intestinal tissues (El Shenawy et 
al., 2008). Intraperitoneal and oral administration of ethanol, chloroform and 
aqueous seed extracts of N. sativa, showed antimalarial activity against 
Plasmodium berghei in mice (Abdulelah and Zainal-Abidin, 2007). In fact, N. 
sativa attenuates the damage to β-cells of the pancreas following exposure to metal 
and toxic elements (Kanter et al., 2005). Similarly, N. sativa administration 
attenuates the ulcerative effects of ethanol on gastric mucosa by decreasing the 
glutathione-S transferase levels in gastric mucosa (Kanter et al., 2005). N. sativa oil 
was found to be effective as an add-on therapy in patients of insulin resistance 
syndrome (Najmi et al., 2008).  
It has been reported that thymoquinone prevents oxidative injury in various in vitro 
and in vivo studies in rats (Daba and Abdel-Rahman1998; Mansour et al., 2001). It 
has been suggested that thymoquinone may act as an antioxidant agent and 
prevents membrane lipid peroxidation in tissues (Mansour et al., 2002). Moreover, 
it has been demonstrated that N. sativa can significantly prevent hepatotoxicity (Al-
Gharably et al., 1997; Nagi et al., 1999) and might have protective effects against 
nephrotoxicity induced by either disease or chemicals (Abdel -Fattah et al., 2000). 
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The protection was suggested to be related to the ability of thymoquinone to inhibit 
lipid peroxidation. Also black seed oil was shown to be an effective adjuvant for 
the treatment of patients with allergic diseases (Kalus et al., 2003). In another 
clinical study, significant benefits of N. sativa extract in the treatment of acute 
tonsillopharyngitis was shown (Dirjomuljono et al., 2008). 
Furthermore, black seed preparations may have a cancer chemo preventive 
potential and may reduce the toxicity of standard antineoplastic drugs (Salomi et 
al., 1991). In fact, topical application of a black seed extract inhibited the two stage 
initiation-promotion of skin carcinogenesis in mice by croton oil (Salomi et al., 
1991). N. sativa decreases DNA damage and thereby prevents initiation of 
carcinogenesis in colonic tissue secondary to exposure to toxic agents such as a 
zoxymethane (Al-Johar et al., 2008). In fact, sustained delivery of thymoquinone is 
almost as effective in causing apoptosis of colon cancer cells as sustained delivery 
of 5-fluorouracil (Norwood et al., 2007). 
1.1.6 Toxicological properties 
The seeds extract and it is constituents appear to have a low level of toxicity. The 
administration of N. sativa seed extract (50 mg/kg) intraperitoneally to rats for 5 
days did not significantly affect the activities of several enzymes and metabolites 
indicative of hepatic and renal function (El-Daly, 1998). Oral administration of the 
seed oil at dose up to 10 ml/kg in rats and mice did not cause any mortality or overt 
toxicity during the observation period of 2 day (Khanna et al., 1993). This was 
confirmed with a work of Zaoui et al. (2002) on the same dose for up to 12 weeks. 
It was shown that oral administration of N. sativa oil did not cause any mortality or 
significant alteration of the key hepatic enzymes in rats.  
1.2 Effects of Nigella sativa on glucose metabolism 
1.2.1 Hypoglycemic effect 
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Hypoglycemia is a syndrome characterized by a reduction in plasma glucose 
concentration to a level that may induce symptoms of low blood sugar. 
Hypoglycemia typically arises from abnormalities in the mechanisms involved in 
glucose homeostasis.  
The effect of N. sativa on some of the complications of experimental diabetic 
rabbits has been investigated by a number of workers (e.g. Al-Hader et al., 1993; 
El-Zawahrawy and Al-Zahraa, 1998; Meral et al., 2001). Al-Hader et al. (1993) 
reported that intraperitoneal administration of the volatile oil of N. sativa seeds (50 
mg/kg) significantly reduced the fasting blood glucose concentration in the normal 
and hypoglycemic rabbits. Insulin concentration was unaffected by the treatment. 
In rats, an aqueous extract of the seeds of N. sativa was administered orally under 
light ether anesthesia for 7 and 14 days. Blood glucose, insulin level and key 
hepatic enzyme concentrations in serum a histopathological change in the liver in 
both treatment groups was done by El- Daly, 1994.  A significant elevation of 
certain key hepatic enzymes and varying degrees of histopathological changes in 
the liver were documented following oral administration of boiling water extracts 
of seed of N. sativa. An increase in gamma-glutamyl transpeptidase in the absence 
of hepatocyte degeneration were observed following oral administration of N. 
sativa extract and this suggests that these enzymes may have been released due to 
hepatocellular damage caused at the molecular level. 
Prolonged exposure (9 days) of beta-cell aggregates to 20 mmol/L glucose was 
used by Ling and Pipeleers 1996 to examine the effects of chronically elevated 
glucose levels on the survival and function of purified rat beta-cells. It did not lead 
to cell losses, but reduced the amount of insulin secreted in response to glucose. 
This decrease was not caused by cellular desensitization but resulted from the 
lower cellular insulin content after a prolonged imbalance between stimulated rates 
of insulin synthesis and release. It is concluded that chronic exposure of rat beta-
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cells to elevated glucose levels induces a prolonged state of beta-cell activation and 
glucose hypersensitivity rather than glucotoxicity or glucose desensitization. 
Many studies have also examined the antidiabetic effects of N. sativa in normal and 
in diabetic animal models. Crud aqueous extract of N. sativa restore glucose 
homeostasis (Labhal et al., 1997). N. sativa was also shown to enhance liver cell 
insulin sensitivity (Le et al., 2004). The effect of different N. sativa seed extract 
(acidic, neutral and basic) on insulin secretion was studied by Rchid et al. (2004). 
The insulin secretory effects of these extracts were evaluated individually at 
concentrations 0.01, 0.1, 1 and 5 mg/ml, in vitro in isolated rat pancreatic islets in 
the presence of 8.3 mmol/l glucose. It was postulated that the antidiabetic 
properties of N. sativa seeds may be, at least partly, mediated by stimulated insulin 
release, and that the basic sub fraction largely contributes to this stimulatory effect 
(Rchid et al., 2004).  
Study on protective effects of the volatile oil of N. sativa seeds on insulin 
immunoreactivity and ultra structural changes of pancreatic b-cells in STZ-induced 
diabetic rats was done by Mehmet et al. (2010). It is suggest that N. sativa 
treatment exerts a therapeutic protective effect in diabetes by decreasing 
morphological changes and preserving pancreatic b-cell integrity. Consequently, N. 
sativa may be clinically useful for protecting b-cells against oxidative stress. 
Abdelmeguid et al. (2010) investigate the effect of N. sativa extract, oil, and 
thymoquinone on serum insulin and glucose concentration in streptozotocin 
diabetic rats. Which have been significantly decreased the elevated serum glucose 
level and significantly increased the serum insulin levels. In addition, the 
hypoglycemic effect observed could be due to amelioration of beta cells thus 
leading to the increased insulin levels. 
1.2.2 Effects of N. sativa seeds on Oral Glucose Tolerance Test 
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The oral glucose tolerance test (OGTT) measures the body's ability to use a type of 
sugar, called glucose, which is the body's main source of energy. OGTT, a test of 
immense value and sentiment, in favor of using fasting plasma glucose 
concentration alone was seen as a practical attempt to simplify and facilitate the 
diagnosis of diabetes. 
N. sativa have gotten a great therapeutic benefit in diabetic individuals and those 
with glucose intolerance, as it accentuates glucose-induced secretion of insulin, 
besides having a negative impact on glucose absorption from the intestinal mucosa 
(Rchid et al., 2004; Meddah et al., 2009). However to date, little attention has been 
paid to the effects of N. sativa on intestinal glucose absorption. One of this was 
done by Meddah et al., 2009 on the effects of the crud aqueous extract of N. sativa 
seeds on intestinal glucose absorption in vitro using a short-circuit current 
technique and in vivo using an oral glucose tolerance test. It showed directly 
inhibits the electrogenic intestinal absorption of glucose in vitro. On the other 
hands there was improvement of glucose tolerance and body weight in rats after 
chronic oral administration in vivo.  
1.2.3 Effects of N. sativa seeds on glucose-6-phosphate dehydrogenase activity 
G6PDH is the key rate-limiting enzyme of the pentose phosphate pathway in 
glucose metabolism. One of the important roles of this pathway is the generation of 
NADPH in the cytoplasmic fraction of the cell. The reducing power of NADPH is 
utilized for various synthetic processes, especially for synthesis of fatty acids. Thus 
G6PDH participates in the regulation of both lipogenesis and glucose metabolism 
(Kelley and Kletzien, 1984). 
Chandrasekaran and Leelavinothan (2009) reported that an oral administration of 
Thymoquinone (major constituent of N. sativa seeds) for 6 weeks, dose 
dependently improved the glycemic status in streptozocin-nicotinamide induced 
diabetic rats. The levels of insulin, Hb increased with significant decrease in 
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glucose and HbA1c levels. The altered activities of carbohydrate metabolic enzymes 
were restored to near normal. In diabetic state the activities of hexokinase and 
glucose-6-phosphate dehydrogenase are decreased as a result of total absence or 
insufficiency of insulin. No significant changes were noticed in normal rats treated 
with thymoquinone. These result show that thymoquinone at 80 mg/kg is 
associated with beneficial changes in hepatic enzyme activities and there by exert 
potential antihyperglycemic effects.  
1.3 Effects of N. sativa seeds on Hemoglobin level 
The effect of N. sativa seeds fixed oil in rats has been investigated by Zaoui et al. 
(2002) by monitoring blood homeostasis and body weight as well as toxicity. Daily 
treatment by an oral dose of 1ml/kg body weight of N. sativa seeds fixed oil for 12 
weeks .Significantly increased level of Hematocrit and Hemoglobin was found by 
6.4% and 17.4% respectively. 
Treatment of rats with the seed extract for up to 12 weeks has been reported to 
induce changes in the hemogram that include an increase in both the packed cell 
volume (PCV) and hemoglobin (Hb), and a decrease in plasma concentrations of 
cholesterol, triglycerides and glucose (Ali and Gerald, 2003). 
1.4 The effect of N. Sativa seeds on serum Alanine transaminase (ALT) 
The Alanine transaminase (ALT) enzyme is found principally in the liver with only 
small amounts being present in other organs. When there is liver cell damage, the 
serum or plasma levels of the enzyme are raised (Cheesbrough, 1989). Al-Jishi and 
Abuo Hozaifa, (2003), investigated the effects of N. sativa powdered seeds on 
blood coagulation and some liver function tests in male rats. The result showed an 
increase in ALT activity. In other study an aqueous extract of the N. sativa seeds 
was administered orally for 7 and 14 days. The result showed a significant increase 
in serum ALT concentration (El-Daly, 1994). Also serum ALT concentration was 
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significantly increased when aqueous extracts of the seeds of N. sativa were 
administered orally to male rats (Tennekoon, et al., 1991). 
1.5 The effects of N. sativa seeds on body weight 
The animal body weight is an important indicator of general health. N. sativa diets 
did not adversely affect growth (Al-Homidan et al., 2002). Another three studies 
with regard to the effect of N. sativa (10 and 20 g/kg) on growth were carried out 
with broilers over periods of 35 days. The body weight did not show any 
differences between control and N. sativa treated groups at the end of the 
experimental period (Brake, 2004). 
1.6 Glibenclamide 
Glibenclamide, also known as glyburide, is an anti-diabetic drug in a class of 
medications known as sulfonylureas. It is sold in doses of 1.25 mg, 2.5 mg and 
5 mg, under the trade names Diabeta, Glynase and Micronase in the United States 
and Daonil, Semi-Daonil and Euglucon in the United Kingdom. It is also sold in 
combination with metformin under the trade name Glucovance. 
1.6.1 Uses of Glibenclamide 
It is used in the treatment of type II diabetes. Since 2007, it is one of only two oral 
anti-diabetics in the World Health Organization Model List of Essential Medicines. 
Sulfonylureas have been used for type 2 diabetes for over 50 year and are still the 
leading class of oral anti hyperglycemic agents. Their popularity is based on 
familiarity and habit, of course, but also their easy of administration (as once-daily 
tablets, in many cases), reliable effectiveness for recently diagnosed patients, lack 
of symptomatic side effects other than hypoglycemia, and low cost (Riddle, 2003). 
1.6.2 Mechanism of action 
The drug works by blocking ATP-sensitive potassium channels in pancreatic beta 
cells (Schmid-Antomarchi et al., 1987; Serrano-Martín et al., 2006). This inhibition 
causes cell membrane depolarization, which opens voltage-dependent calcium 
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channels, which causes an increase in intracellular calcium in the beta cell, leads to 
stimulates insulin release. 
Six patients with type 2 diabetes underwent detailed metabolic studies before and 
after a minimum of 3 month's Glibenclamide therapy. Treatment was associated 
with a small but significant increase in body weight. Despite improvements in 
almost all the measured parameters of glucose homeostasis include plasma glucose, 
glycosylated hemoglobin (HbA1), hepatic glucose production and insulin-mediated 
glucose disposal (Baynes et al., 1993). 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1 Experimental details 
These experiments were carried out to investigate the hypoglycemic effect of 
Nigella sativa seeds and how glucose metabolism is modulated in Wister albino 
female rats fed the black seeds. 
2.1.1 Experimental animals 
Thirty female Wister albino rats weighing 65g to 115g were used in this 
experimental study. They were randomly picked up from the experimental breeding 
station at Department of Preventive Medicine, Faculty of Veterinary Medicine. The 
rats were initially fed a standard basal laboratory rat diet for 7 days to be 
acclimatized to the laboratory environment. All animals were maintained under 
standard conditions (temperature 27-30°C, 12 h natural light and 12 h darkness); 
they were housed identically in stainless cages and were supplied with water and 
rodent chow ad libitum.  
2.1.2 The basal rat diet 
The rats were given a basal rat diet of the following composition: 
Wheat flour  690g 
Meat powder  165g 
Oil   120g 
Sodium chloride 4g 
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Nigella sativa seeds were obtained from the South western Ethiopia. The viability 
of N. sativa seeds was confirmed by germination test according to Ista, (1976). The 
rats were divided into five groups. For each group the calculated treatment was 
mixed with 2g of the basal diet for each rat and fed to the animals first. Then the 
rest of the measured daily requirements for each rat, 6g from the basal rat diet, were 
supplied to the experimental animals. 
2.1.3 Equipments 
• Test tubes. 
• Racks. 
• Gloves. 
• Capillary tubes. 
• Pipettes.  
• Tips.  
• Centrifuge.  
• Spectrophotometer. 
• Florid Oxalate Blood Collection tube. 
• EDTA Blood Collection tubes. 
• Plane Blood Collection tubes. 
• Eppendorf tubes. 
2.2 Methods 
2.2.1 Germination test 
N. sativa seeds were obtained from Omdurman Market. The viability of N. sativa 
seeds was confirmed by germination test according to Ista (International Seed 
Testing Agency), 1976.  Germination test was performed as follows: 
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1- 100 seeds were selected randomly and divided into four groups, 25 seeds in 
each one. 
2- Each group of the seeds was placed in a dish containing a wet filter paper and 
incubated in incubator at 20oc for seven days. 
3- On day four, the normal seedling that developed was count. 
4- On day seven, the final count of the germination seeds was done. 
5- All four set of germinated seeds should have a germination rate of at least 
85%. 
6- A germination rate of 85% is 85 normal seedlings of 100 seeds. 
The seeds tested showed germination rate more than 85% and considered viable.  
The seeds identification was done by Mr. Hamza Tag-Elsir Osman, Department 
of Botany and Agricultural Biotechnology, Faculty of Agriculture, University of 
Khartoum.  
2.2.2 Experimental procedure  
The Wister albino rats were divided into five groups A, B, C, D, and E, each 
containing six rats. They were fed 8g normal basal rat’s diet per day for each rat. 
The control group (A) was fed normal basal rats diet, while the treated groups (B, 
C, D and E) were fed normal rat’s diet plus the following treatments calculated as 
part from the 8 g of the basal diet for each rat. 
Group (B): received Glibenclamide (Produced by CP Pharmaceuticals Ltd 
Wrexham UK) 10mg/kg body weight. 
Group (C): received N. sativa seeds 50mg/day for each rat (El-Daly, 1998). 
Group (D): received N. sativa seeds 50mg/day for each rat + glucose 2g/kg body 
weight. 
Group (E): received glucose 2g/kg body weight. 
Blood samples were collected from at the zero, 7th, 14th, 21th and 28th days.  
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2.2.3 Blood samplings  
After 1 h of feeding 2g of experimental diet mixed with treatment, at zero time then 
after 1, 2, 3 and 4 weeks after treatment, 1 ml of blood sample was collected from 
the orbital venous plexus by plain capillary tubes into fluorinated test tubes    ( to 
avoid glycolysis by RBCs) for blood glucose determination. Plasma separated 
spontaneously after centrifugation at 5000 rpm for 10 min, and then blood glucose 
concentration was measured. Also at 14th and 28th days of experiment, blood 
samples were collected in plain containers for insulin concentration. Serum was 
separated and stored in clean labeled aliquots at -20oc until analyzed. For Alanine 
aminotransferase (ALT) activity blood samples were collected at the 30th day of the 
experiment from the orbital plexus by plain capillary tubes in fluoride containers. 
Plasma was stored in clean labeled aliquots at -20oc until analyzed for ALT 
activity. At day 30, Blood samples were also collected in EDTA tubes for 
Hemoglobin determination and glucose-6-phosphate dehydrogenase activity 
(G6PD). Plasma was separated by centrifugation at 5000 rpm for 10 min for G6PD 
determination.  
2.2.4 The body weight 
Rats were weighed at the beginning and the end of the experiment. 
2.2.5 Histopathological examinations 
At the end of the experimental period, the rats were slaughtered and specimens of 
liver and pancreas were taken immediately and fixed in 10% formaline for 
histopathology. 
2.3 Analytical methods 
2.3.1 Determination of plasma glucose 
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Glucose concentration was determined according to the method described by 
Trinder, (1969) and Teuscher et al., (1971). 
Principle 
The oxidation of glucose is catalysed by glucose oxidase (GOD). The resultant 
hydrogen peroxide (H2O2) is oxidatively coupled with 4-aminophenazone and 
phenol in the presence of peroxidase (POD) to yield a red quinoneimine dye, the 
concentration of which at 546 nm is proportional to the concentration of glucose. 
Alpha-D-glucose    Mutarotase   beta-D-glucose. 
Beta-D-glucose + H2O + O2  GOD            D-gluconic acid + H2O2 
H2O2 + 4-aminophenazone + phenol   POD    quinoneimine + 4H2O  
Reagent composition 
1- Phosphate buffer (PH 7.5)  0.1mol/l 
4- Aminoantipyrine   0.25mmol/l 
Phenol     0.75mmol/l 
Glucose oxidase   15KU/I 
Peroxidase    1.5KU/I 
Mutarotase    2KU/I 
2- Glucose standard   100mg/dl or 5.5mmol/l 
Procedure 
1- Three test tubes were labeled as blank, standard and test.  
2- 1 ml of working reagent was pipette into each one. 0.01 ml distelled water 
was pipetted into the blank tube, 0.01ml of glucose standard was pipetted 
into the standard tube, and 0.01ml plasma was pipetted into test tube. 
3- Tubes were mixed and incubated for 10 min at 20 – 25oc. 
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4- 1ml content of each tube was delivered into cuvette and the absorbance of 
the sample and standard were read against the blank at 500 nm using 
spectrophotometer.  
Calculations 
 Glucose (mg/dl) =    A sample  x concentration of standard  
      A standard  
2.3.2 Determination of glucose-6-phosphate dehydrogenase activity (G6PD) 
The determination of G6PD activity was done according to the method of Rodak, 
(1995). 
Principle 
G6PD in the RBCS is released by a lysing agent present in the reagent. The G6PD 
released catalyzes the oxidation of glucose-6-phosphate with the reduction of 
NADP to NADPH. The rate of reduction of NADP to NADPH is measured as 
increase in absorbance, which is proportional to the G6PD activity in the sample. 
Glucose-6-phosphate + NADP  G6PDH  Gluconate-6-phosphate+NADPH+ H+ 
Procedure 
1- 1ml of G6PD working reagent was pipetted into cuvette. 
2- 0.01ml of whole blood with EDTA was added. The cuvette content was 
mixed well and incubated for 5 min at 30oc.  
3- 2ml of starter reagent was added, mixed well and incubated for another 
5min at 30oc. 
4- The initial absorbance A was read and the absorbance reading was 
repeated after every 1, 2 and 3min. 
Calculations 
 A/min =   A2 – A1 
   5 
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G6PD activity (U/g Hb) =  A x      4778 
      Hb (g/dl) 
2.3.3 Determination of insulin 
The determination of serum insulin was done according to Midgley et al., (1969) 
using insulin Radioimmunoassay kit (RIA) IMK-414 (Beijing China, CIAE 1995). 
Principle 
The radioimmunoassay method in this test depends upon the competition between 
iodine-125 labeled insulin and insulin in the sample (or in standard) for the limited 
number of binding site on insulin specific antibody. After incubation for fixed time, 
separation of bound from free is achieved by the PEG-accelerated double-antibody 
procedure. The tube is then counted in a gamma counter, the counts being inversely 
related to the amount of insulin present in the sample. By measuring the proportion 
of iodine-125 labeled insulin bound in the presence of varying known amount of 
insulin standards, the concentration of insulin in known samples can be interplated. 
Assay protocol 
1- Assay tubes were labeled and arranged in the assay rack. 
2- 100 µl, 200 µl aliquots of buffer were pipetted into insulin standard (0), NSB 
tube respectively. 
3- 100 µl of insulin antibody solution were pipette into all tubes except total and 
NSB tubes. 
4- 100 µl of iodine – 125 labeled insulin solutions were pipetted to all tubes. 
5- The tubes were mixed thoroughly and incubated at 37oc for 2 hours, the total 
count tubes were been set aside at this stage. 
6- 500 µl of separating agent solution were pipetted to all tubes except total 
count tubes. Then tubes were mixed thoroughly and placed at 37oc for 15 
min. 
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7- All tubes were centrifuged at 1500xg for 15min except total count tubes, and 
the supernatants were decanted carefully. 
8- All tubes were counted in a gamma counter. 
Calculations 
NSB%  =  NSB – Back grand cpm     x 100 
     Total counts cpm – Back grand cpm  
Maximum binding Bo% =       zero standard cpm – NSB cpm          x 100 
           Total counts cpm – Back grand cpm  
B % =      standard (or sample) cpm – NSB cpm   x 100 
 Bo              zero standard cpm – NSB cpm 
2.3.4 Determination of Alanine aminotransferase (ALT) 
The determination of serum ALT activity was done according to the method of 
Gella et al. (1985) and Young, (1997). 
Principle 
Alanine aminotransferase (ALT or GPT) catalyzes the transfer of the amino group 
from alanine to 2-oxoglutarate, forming pyruvate and glutamate. The catalytic 
concentration is determined from the rate of decrease of NADH, measured at 340 
nm; by means of the lactate dehydrogenase (LDH) coupled reaction. 
Alanine + 2-oxoglutarate  ALT  pyruvate + Glutamate  
Pyruvate + NADH + H+   LDH  Lactate + NAD+ 
Reagents composition 
  Reagent (A): Tris 150 mmol/l, L-alanine 750 mmol/l, Lactate 
dehydrogenase >1350U/L, PH 7.3. 
  Reagent (B): NADH 1.3 mmol/l, 2-oxoglutarate 75 mmol/l, sodium 
hydroxide 148 mmol/l, sodium azide 9.5 g/l. 
Procedure 
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1- Working reagent and the instrument were brought to reaction 
temperature. 
2- 1.0 ml of working reagent and 100 µl of sample were pepitted into 
a cuvette at 30oc, mixed and inserted into the photometer. 
3- Initial absorbance was recorded after 1 min and absorbance was 
recorded at 1 min intervals thereafter for 3 min. 
4- The difference between the consecutive absorbance and the average 
absorbance difference per min (      A/min) were calculated. 
Calculations 
ALT concentration (U/L) =      A/ min x   Vt x 106 
           E x I x Vs 
Whereas: 
Vt:  equal 1.1 at 30oc. 
E:  the molar absorbance of NADH at 340 nm is 6300. 
I:  1 cm light bath. 
Vs:  equal 0.1 at 30oc.  
2.3.5 Hemoglobin estimation 
Haemoglobin (Hb) concentration was determined by cyanmethaemoglobin method 
as describe by Van Kampen and Zijlstra (1961). 
Principle 
Ferrous ions of Hb are oxidized to the ferric state by potassium ferricyanide to 
form methemoglobin, which reacts with cyanide to form cyanmethemoglobin that 
can be measured colorimetrically. 
Reagents 
Cyanide reagent (Drabkin’s solution) 
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The reagent was prepared by dissolving 0.2g potassium cyanide, 0.05g of 
ferricyanide and 0.14g of potassium hydrogen diorthophosphate in 1 litre of 
distilled water. 
Standard Hb solution 
One ml of human Hb standard (Biosystem-Spain), with a concentration of 14.6 g/dl 
was used as standard. 
Procedure 
1- Dry clean test tubes were prepared for sample and standard.  
2- To each tube, 4 ml of cyanide reagent were added. Then 0.02 ml of blood 
sample and Hb standard solution were added to the samples and standard 
tube, respectively.  
3- The tubes were allowed to stand for 15 min, and then the optical density 
(O.D) was read at 540 nm in the colorimeter using cyanide reagent as blank. 
Calculation 
      Hb concentration (g/dl) =     O.D sample   × 14.6 
                                                 O.D standard 
2.4 Oral glucose tolerance test (OGTT) 
Oral glucose tolerance test was performed according to the method of Du Vigneand 
and Karr, (1925). 
 Rats were fasted for 16 hour before being subjected to OGTT by intragastric 
gavages with glucose solution to achieve a glucose load of 2 g/kg body weight. 
Blood samples were collected from the orbital venous plexus by plain capillary 
tubes at 0, 30, 60, 90 and 120 min and blood glucose was determined. 
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2.5 Histopathological methods 
Rats were killed at the end of the experiment. The liver and pancreas were 
harvested, cut into a small pieces and were fixed in 10% formalin. They were 
embedded in paraffin and were cut into 5 µm thickness in microtome. These 
sections were collected in slides and then stained with Hematoxylin and Eosin 
before observation under light microscopy (Steward, 1960). 
2.6 Statistical analysis 
Data collected in various experiments were subjected to appropriate general linear 
model (GLM) procedure of the statistical analysis using the SAS package. The SAS 
was used to perform analysis of variance (ANOVA) and mean separations were 
performed using Ryan-Einot-Gabriel-Welsch Multiple F test (REGWQ) (Day and 
Quinn, 1989).  
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CHAPTER THREE 
RESULTS 
 
The present study was carried out to investigate the hypoglycemic effects of 
Nigella sativa seeds and to show how glucose metabolism is modulated in normal 
Wister albino female rats. The results were included estimation of serum glucose, 
serum insulin and Oral Glucose Tolerance Test. Activities of glucose-6-phosphate 
dehydrogenase and Alanine aminotransferase enzymes were assayed. Hemoglobin 
concentration and animal body weight were also measured. In addition to the 
histopathological changes of the liver and pancreas were examined. 
3.1 The effects of feeding N. sativa seeds on blood glucose concentration 
The effect of the treatments on glucose concentration is presented in table (1) and 
(2). 
The Glibenclamide treated group (B) demonstrated a highly significant decrease 
(p<0.001) in the serum glucose level compared to the control group (A) at 7 and 21 
days of the experiment. A significant (p<0.01) decrease was also seen at 14 and 28 
days compared to the control group. The total mean of glucose level of the different 
days is significantly (p<0.001) decreased compared to the total mean of the control 
group. The N. sativa treated group (C) showed a significant (p<0.01) decrease in 
plasma glucose level compared to the control group at all intervals. The total mean 
of glucose of the different days showed a significant decrease in glucose level in 
group (C) compared to the control group. N. sativa + glucose treated group (D) 
revealed a significant decrease (p<0.001) in serum glucose level compared to the 
control group after 7 days of treatment, but no significant difference was observed 
after 14, 21 and 28 days of treatment compared to the control group. The total mean 
of glucose of the different days showed a significant decrease in glucose level in 
group (D) compared to the control group. On the other hand treatment with glucose 
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in group (E) showed a significant (p<0.001) decreased in serum glucose level after 
7 days of treatment and showed no significant difference after 14 to 28 days of 
treatment compared to the control group. The total mean of glucose at different 
days showed no significant decrease in glucose level in group (E) compared to the 
control group (table 1 and 2). 
Table (1): The changes in the serum glucose concentration (mg/dl) among the 
different groups of rats at different time intervals 
 
   Group  
Time 
 
Group A 
 
Group B 
 
Group C 
 
Group D 
 
Group E 
 0 day 67.750±4.49a 65.340±7.61a 52.350±6.16a 57.950±5.09a 67.983±2.00a
 
7 days 93.940±3.28a 26.367±4.81c 50.250±9.50b 50.880±3.98b 51.975±3.03b
 
14 days 47.740±4.53a 21.950±2.75b 26.050±3.68b 48.325±5.49a 48.767±8.12a
 
21 days 73.425±6.05a 21.220±3.51c 47.080±7.08b 67.420±3.46a 81.800±4.38a
 
28 days 35.675±2.77a 20.340±1.96c 27.300±3.47b 33.920±4.22a 34.175±2.94a
 
Mean ± SE within the same row with different superscript small letters are 
significantly different at (p<0.01) based on ANOVA. 
Group A: control group (received normal diet). 
Group B: Glibenclamide treated group. 
Group C: N. sativa treated group. 
Group D: N. sativa + glucose treated group. 
Group E: glucose treated group. 
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3.2 Blood insulin level 
The effect of the four treatments on the level of the insulin is presented in table (2) 
and fig. (1). 
There is no significant different in the level of serum insulin in groups B, C, D and 
E after 14 days treatment compared to the control group A. whereas, there is a 
significant (p<0.01) increase in the level of serum insulin in groups B, C, D and E 
after 28 days treatment compared to the control group A. In groups B, C and E 
there is a significant increase in insulin level after 28 days compared to the level 
after 14 days of treatment. There is insignificant increase in insulin level at 28 days 
of treatment in group D compared to day 14. 
Table (2): The changes in the serum insulin concentration (µIU/ml) in the 
treated and control groups of rats 
   Group    
Time 
 
Group A 
 
Group B 
 
Group C 
 
Group D 
 
Group E 
 14 days 5.875±0.66a 5.775±1.22a 5.520±0.82a 7.525±1.32a 9.725±0.84a
 
28 days 5.833±1.97a 10.460±1.24 a b 10.480±1.47a b 10.660±1.74a b 15.700.43b
 
Mean ± SE within the same row with different superscript small letters are 
significantly different at (p<0.01) based on ANOVA. 
Group A: control group (received normal diet). 
Group B: Glibenclamide treated group. 
Group C: N. sativa treated group. 
Group D: N. sativa + glucose treated group. 
Group E: glucose treated group. 
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Fig. (1): The effect of N. sativa seeds on serum insulin level (µIU/ml) day 14th 
and 28th 
  
Bars having different small superscript letters are significantly different at (p<0.01) 
based on ANOVA. 
Group A: control group (received normal diet). 
Group B: Glibenclamide treated group. 
Group C: N. sativa treated group. 
Group D: N. sativa + glucose treated group. 
Group E: glucose treated group. 
 
 
 
 
 
 
 
Ta Ta Ta
Ta
Ta
Ta
Tab Tab Tab
Tb
0
2
4
6
8
10
12
14
16
18
A B C D E
In
su
lin
 (m
IU
/m
l) 
Groups
day14th 
day 28th 
 
 
30
3.3 Oral glucose tolerance test (OGTT) 
Results of OGTT carried out for the control and different experimental groups after 
the end of the experimental period are showed in fig. (2). 
 After the application of the oral dose of glucose in group (A) the control the blood 
glucose increased significantly (p<0.05) after 30 min but for groups (D and E) the 
significant increase (P<0.05) was seen after 60 min (with very high score in group 
E) and for group (B and C) was seen after 90 min. The blood glucose level returned 
to the fasting levels after 2 h for all groups except groups (B and C) where it was 
still significantly (P<0.05)  higher than the fasting level.  
Fig. (2): The effect of N. sativa seeds on oral glucose tolerance test 
 
Values are mean ± SE of each group. (p<0.05) based on ANOVA. 
Group A: control group (received normal diet). 
Group B: Glibenclamide treated group. 
Group C: N. sativa treated group. 
Group D: N. sativa + glucose treated group. 
Group E: glucose treated group. 
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3.4 Glucose-6-phosphate dehydrogenase activity (G6PD) 
The effect of feeding N. sativa to normal albino rats for four weeks is presented in 
table (4). 
The activity of G6PD showed no significant change in groups B, C, D and E. only  
numerically lower levels were observed in groups B and C and higher levels were 
observed in groups D and E  compared to the control group (A) after 28 days of the 
experiment. 
3.5 Alanine aminotransferase activity (ALT) 
The levels of ALT activity in the different treated groups are presented in table (4). 
The serum ALT activity at the end of the experiment is significantly (p<0.001) 
decreased in group B compared to the control group (A). Whereas a significant 
increase in serum ALT activity was seen in group C compared to the control group. 
ALT activity is not significantly different in group D compared to the control 
group. In addition, there is a significant (p<0.001) decrease in ALT activity in 
group E compared to the control group (fig.3) 
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Fig. (3): The effects of N. sativa seeds on Alanine aminotransferase activity 
(U/L) in the different treated groups of rats 
 
Bars having different small superscript letters are significantly different at 
(p<0.001) based on ANOVA. 
Group A: control group (received normal diet). 
Group B: Glibenclamide treated group. 
Group C: N. sativa treated group. 
Group D: N. sativa + glucose treated group. 
Group E: glucose treated group. 
3.6 The effects of N. sativa seeds on Hemoglobin concentration  
The levels of Hemoglobin concentration in the different groups is presented in table 
(2). 
There is no significantly different between group B, C, D, and E and control group 
(A) in hemoglobin concentration after 28 days of the experiments.  
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3.7 The effects of N. sativa seeds on body weight 
Changes in body weight in the different groups of rats are presented in table (3) and 
(4). 
There is no significant different between group B, C, D, and E and control group 
(A) with respect to body weight at 0 and 30 days of the experiment.  
Table (3): The effects of seeds on body weight (g) 
      Group 
  Time      
Group A Group B Group C Group D Group E 
0 day  93.4±4.86a 94.2±5.49 a 92.5±4.83 a 89.0±6.56 a 95.3±5.75 a
 
30 days 106.2±4.04 a 101.8±7.37 a 103.5±5.86 a 107.4±7.61 a 116.3±4.21 a
 
Mean ± SE within the same row with different superscript small letters are 
significantly different at (p<0.05) based on ANOVA. 
Group A: control group (received normal diet). 
Group B: Glibenclamide treated group. 
Group C: N. sativa treated group. 
Group D: N. sativa + glucose treated group. 
Group E: glucose treated group. 
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Table (4): Biochemical and Hemoglobin concentration changes in rats  
 
          Groups 
Parameters 
Group A Group B Group C Group D Group E 
G6PD  
(U/g Hb) 
9.88±1.34a 6.40±1.71 a 7.28±0.93 a 12.44±2.61 a 11.40±3.54 a 
ALT (U/L) 
 
41.33±8.27 a 23.83±1.47b 53.83±2.33c 38.70±2.29 a 28.80±1.82 b 
TMG (mg/dl) 
 
63.89±4.5a 30.53±4.3c 41.30±3.9b 52.08±2.9b 57.21±3.9a
TMI (µIU/ml) 5.85±0.8 a 8.38±1.4 a b 8.0±1.1 a 9.27±1.2 a b 12.71±1.4 b 
 
Hb (g/dl) 
 
11.92±0.36a 8.80±0.67 a 11.43±1.15 a 11.78±1.15 a 10.50±1.05 a 
TMBW (g) 
 
99.80 ± 3.7 a 98.0±4.5 a 
 
98.0 ±3.9 a 98.20±5.6 a 105.75 ±5.1 a 
Mean ± SE within the same row with different superscript small letters are 
significantly different at (p<0.05) based on ANOVA. 
Group A: control group (received normal diet). 
Group B: Glibenclamide treated group. 
Group C: N. sativa treated group. 
Group D: N. sativa + glucose treated group. 
Group E: glucose treated group. 
Abbreviations: G6PD, clucose-6-phosphate dehydrogenase; ALT, alanine 
aminotransferase; TMG, total mean of glucose; TMI, total mean of insulin; Hb, 
hemoglobin; TMBW, total mean of body weight. 
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3.8 Histopathological findings 
The histological evaluation of pancreas in group B, C, D and E revealed normal 
and healthy microscopic images fully comparable to control group A. The 
histology of liver was normal in group C and D compared to the control group A 
(fig. 4, 6 and 7). There is a focal infiltration of mononuclear cells especially around 
blood vessels in group B (fig. 5). There is a focal infiltration of mononuclear cells 
especially around blood vessels, some hepatocytes exhibit fatty degeneration and 
focal areas of necrosis in glucose treated group E (fig. 8). 
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Fig. (4): liver from rats received normal basal rat’s diet. Notice no changes. (H 
and E X 400). 
 
 
 
 
 
37
 
 
 
 
Fig. (5): liver from rats received Glibenclamide (10mg/kg body weight) on 
feed. Notice a focal infiltration of mononuclear cells especially around vessels. 
(H and E X 400). 
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Fig. (6): liver from rats received N. sativa (50mg/day) on feed. Notice no 
changes. (H and E X 400). 
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Fig. (7): liver from rats received N. sativa (50mg/day) +glucose (2g/kg body 
weight) on feed. Notice no changes. (H and E X 400). 
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Fig. (8): liver from rats received 2g/kg body weight glucose on feed. Notice that 
some hepatocytes exhibit fatty degeneration and focal areas of necrosis. (H 
and E X 400). 
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CHAPTER FOUR 
DISCUSSION 
 
Nigella sativa (N. sativa) is widely traditionally used as hypoglycemic plant in the 
Middle East, Northern Africa and Asia for treatment of various diseases.  Many 
studies proved that N. sativa has hypoglycemic effects (Uddin et al., 2002; Uddin 
et al., 2005). The present study deals with its hypoglycemic effect and how this can 
modulate glucose metabolism. Wister albino female rats were used as experimental 
animals.   
Normal glucose homeostasis represents the balance between intake (glucose 
absorption from the gut), tissue utilization (glycolysis, pentose phosphate pathway, 
tricarboxylic acid cycle, glycogen synthesis) and endogenous production 
(glycogenolysis and gluconeogenesis) (Meyer et al., 2002). By this way, the body 
tries to keep a constant glucose supply for cells by maintaining a constant blood 
glucose level.  
4.1 The effects of feeding N. sativa seeds on serum blood glucose concentration 
Glucose is the most important carbohydrate in mammalian biochemistry because 
nearly all carbohydrates in food are converted to glucose for further metabolism. 
Blood glucose is derived from the diet, gluconeogenesis and from glycogenolysis. 
In the present study blood glucose levels were decreased significantly in group 
treated with Glibenclamide treated group B, N. sativa treated group C and N. sativa 
+ glucose treated group D compared to the control group A. There was 
insignificant decreased in blood glucose level in glucose treated group E. 
Similar observations were obtained by Al-Awadi et al. (1985), who reported that 
plant mixture extract comprising of N. sativa, Myrrh, Gum olibanum, Gum 
asafetida  have a blood glucose lowering effect. It stated that the N. sativa induced 
increases in serum insulin concentration in rats which was accompanied by a 
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decrease in blood glucose level (Al-Awadi et al., 1985).   Also Zaoui et al. (2002) 
suggested that the daily gavages of hexane extract of N. sativa seeds in Wister-
kyoto rats for 12 weeks had reduced blood glucose level. Also N. sativa was 
studied by Alhader et al. (1993) and Sinada, (2007) showed a significant 
hypoglycemic effect. 
The results obtained in the present study were also agree with El-Daly, (1994) who 
indicated that blood glucose level significantly decreases in a group treated with N. 
sativa for 7 and 14 days. Also significant increases in serum insulin level were 
observed after treatment of N. sativa and there was significant decrease in blood 
glucose level in a study by Farah, (2002). Other data showed that the hypoglycemic 
effect of N. sativa occurred by oral treatment (20 mg/kg) N. sativa resulted, at least 
partly, from stimulatory effect on B- cell function with consequent increase in 
serum insulin level. Similarly (Eskander et al., 1995) and (El-shabrawy and Nada, 
1996) were reported the hypoglycemic effect of N. sativa in combination with other 
herbs in alloxan-induced diabetic rats.  
N. sativa seeds are known to reduce blood glucose level in different animal species 
(Haddad et al., 2003). These results were in line with the Kamal, (2006), who 
reported that oral administration of water extract, N. sativa (30 ml/kg body weight) 
significantly decreased serum glucose level in diabetic rats from 19.8 mmol to 9.7 
mmol and increased serum insulin level from 0.5 mIu/l to 0.7 mIu/l. It is also  agree 
with Abdelmeguid et al. (2010), as they reported that N. sativa extract, oil and 
thymoquinone significantly decreased the elevated serum glucose level and 
significantly increased the serum insulin levels in streptozotocain induced diabetic 
rats. He suggested that the hypoglycemic effect observed could be due to 
amelioration of B- cells thus leading to the increased insulin level. 
The mechanism of glucose reduction was reported by Kamal, (2006) who 
suggested that N. sativa seeds induce preserving pancreatic B- cell integrity, thus 
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attributing to increased glucose metabolism, by increasing the serum insulin. On 
the other hand, Farah et al. (2004) suggested that the reduction of blood glucose 
from 391 mg/dl before treatment to 197 mg/dl after treatment in hamster is due 
significantly to the low hepatic glucose production from gluconeogenic precursors.  
4.2 The effects of feeding N. sativa seeds on insulin level 
Insulin is a hormone that affects the carbohydrates metabolism by enhancing the 
rate of glucose metabolism, decreasing blood glucose concentration and increasing 
glycogen storage in tissues.  
In the present study, there was no significant difference in the insulin level in 
Glibenclamide treated group B, N. sativa treated group C, N. sativa + glucose 
treated group D and glucose treated group E compared to control group A at day 
14th  of the experiment. Whereas, there were a significant (p<0.01) increased in 
insulin level in group B, C, D and E after 28 days of the experiment compared to 
the control group. In group B, C and E there is a significant increase in insulin level 
after 28 days compared to 14 days of treatment. Whoever, there is insignificant 
increase in insulin level at 28 days of treatment in group D compared to day 14.  
The findings could agree with Al-Daly, (1994), who reported significant increase in 
serum insulin level after administrating aqueous extract of N. sativa seeds orally 
under light ether anesthesia for 7 and 14 days to rats. Similarly, Halit et al. (2002) 
reported that N. sativa treatment had increased the lowered insulin levels in rats. 
Moreover, Rchid et al. (2005) and Sinada, (2007) reported that using of different 
doses of N. sativa had caused significant increase in serum insulin levels.  
Gyton, (1966), presented the feedback mechanism between glucose and insulin, 
when glucose concentration becomes elevated, the excess glucose acts directly on 
the islets of langerhans to increase their secretion of insulin. Almost immediately, 
more insulin become available to cause glucose transport into most cells of the 
body, and this reduces the blood glucose level back towards normal. Goodner and 
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Porte (1972) reported that when beta cells are stimulated the insulin is discharged; 
this is then followed by a refractory period in which responses to other wise potent 
stimuli then promotes a second sustained secretion. 
The increase in serum insulin level was observed by Farah, (2002), who suggested 
that, the increase in serum insulin levels resulted from stimulatory effect of N. 
sativa on B- cell function, which indicated that N. sativa has insulinotropic 
properties. In contrast, Al-Hader et al. (1993) reported that the volatile oil of N. 
sativa had produced a significant hypoglycemic effect on normal and alloxan-
induced diabetic rabbits without changes in insulin levels. 
4.3 The effects of feeding N. sativa seeds on oral glucose tolerance test  
After the oral dose of glucose in normal control group the blood glucose 
significantly (p<0.05) increase at 30 and 60 min and then decreased  at 90 min and 
reached the fasting levels at 2 h. on the other hand blood glucose in Glibenclamide 
treated group a significant (p<0.05) increase after 30, 60 and 90 min and 
insignificant decreased after 2 h. Treatment with N. sativa showed insignificant 
increase in serum glucose level after 30 min, a significant (p<0.05) increase in the 
serum glucose level after 60 min and showed a significant (p<0.05) decrease in the 
serum glucose level after 90 and 120 min of oral glucose dose to near normal. 
These results showed that similar behavior was seen in the groups that received 
Glibenclamide or only N. sativa. Treatment with N. sativa + glucose showed 
insignificant increase in serum glucose level after 30 min, a significant (p<0.05) 
increase in the serum glucose level after 60 and 90 min and showed a significant 
(p<0.05) decrease in the serum glucose level after 120 min of oral glucose dose. 
There is no significant different in glucose concentration after 120 min compared to 
0 min. Treatment with glucose showed a significant (p<0.05) increase in serum 
glucose level after 30 and 60 min, a significant (p<0.05) decrease in the serum 
glucose level after 90 and 120 min of oral glucose dose. 
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These results therefore confirm the reduction of intestinal transport in vivo and are 
consistent with increased insulin sensitivity observed in previous studies (Le et al., 
2004). They are also in agreement with results Al-Awadi et al., (1985) who 
obtained an improved OGTT response in normal and streptozotocin rats treated 
with a mixture of plants containing N. sativa. Indeed, in subsequent studies, the 
same group failed to observe an improvement of fasting blood glucose or OGTT 
response with N. sativa alone administered again at 0.5 g/kg for 1 week (Al-Awadi 
and Gumaa, 1987).   
Bouchra et al., 2008 reported that an OGTT challenges were carried out acutely at 
the beginning of the study, 2h after the first N. sativa gavages, and chronically at 
the end of 6-week treatment regimen. N. sativa was without significant effect after 
acute administration but reduced the overall OGTT response after chronic 
treatment.  
4.4 The effects of feeding N. sativa seeds on glucose-6-phosphate 
dehydrogenase activity 
Liver plays a central role in blood sugar homeostasis. In diabetic state the activities 
of hexokinase and glucose-6-phosphate dehydrogenase are decreased which due to 
the total absence or insufficiency of insulin (Chandrasekaran and Leelavinothan, 
2009). Thymoquinone up regulates the activities of both these enzymes in hepatic 
tissues through insulin release and thereby it enhances the utilization of glucose for 
cellular biosynthesis, which is marked by the significant decrease in plasma 
glucose level (Chandrasekaran and Leelavinothan, 2009).  
The activity of G6PD is insignificantly changed in group B, C, D and E compared 
to the control group (A) after 28 days of the experiment. The results were agree 
with Chandrasekaran and Leelavinothan, (2009) who reported that an oral 
administration of Thymoquinone (major constituent of N. sativa seeds) for 6 weeks, 
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did not affect the G6PD activity in normal rats, but it significantly decreased in 
diabetic rats.  
4.5 The effects of feeding N. sativa seeds on Alanine transaminase (ALT) 
activity  
ALT is a cytoplasmic enzyme found in very high concentration in the liver. The 
level of ALT in the blood is used as indicator for hepatocytes integrity; disrupt 
hepatic parenchyma cells, with necrosis or the altered membrane permeability, will 
lead to the leakage of the enzyme to the blood stream (Cornelius and Kaneko, 
1986). In the present study the level of serum ALT showed a significant (p<0.001) 
decreased in Glibenclamide treated group and Glucose treated group compared to 
the control group. However, there is a significant (p<0.001) increase in serum ALT 
activity in N. sativa treated group compared to the control group. There is no 
significant change in ALT activity N. sativa + glucose treated group compared to 
the control group. The present study suggested that, 50 mg/day of N. sativa seeds 
for four weeks may slightly affect liver integrity. 
 The results were in line with Tennekoon, et al. (1991) who reported the increase in 
serum ALT in rats consuming aqueous extract of N. sativa (250g/1000ml distilled 
water) for consecutive 14 days when compared to the control group. Also Elhag, 
(1998) who reported that serum ALT activity is slightly increased in rabbits fed 
10% N. sativa seeds for two weeks and maintained level for the rest of the 
experimental period. The oral administration of N. sativa led to marked and 
significant increases in ALT enzyme activity of serum after 7 and 14 days post-
treatment (Al-Daly, 1994).  
4.6 The effects of feeding N. sativa seeds on blood hemoglobin level  
There is no significant (p<0.05) difference between groups B, C, D, and E and 
control group (A) in Hemoglobin concentration at 28 days of the experiments 
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Similarly Chandrasekaran and Leelavinothan, (2009) reported that oral 
administration of thymoquinone in normal rat did not affect the hemoglobin level 
after 45 days of experiment compared to the control group.  
4.7 The effects of feeding N. sativa seeds on body weight  
In the present study initial and final body weight of experimental animals were 
measured .There is no significant different between all treated groups (B, C, D and 
E) compared to the control group with respect to the body weight at the end of the 
experimental period, only group E showed a higher body weight compared to other 
groups.   
Similarly Brake, (2004), reported that administration of N. sativa seeds did not 
causes any differences between the control and treated animals. Also Alhomidan et 
al. (2002), reported that, feeding 20 and 100g/kg body weight of N. sativa seeds to 
7day old broiler chicks did not affect growth. The results were in line with 
Chandrasekaran and Leelavinothan, (2009); they reported that oral administration 
of thymoquinone in normal rat did not affect the body weight after 45 days of 
experiment compared to the control group.  
Similarly Sinada, (2007) has recently reported that the live weight gain in broiler 
chicks was not affected by crushed N. sativa seeds mixed with commercial ration 
compared to the control group. Zaoui et al. (2002) found that the fixed oil of N. 
sativa slow growth rate of normal rats.  
4.8 Histopathological findings  
Histopathological examination of pancreas showed no evidence of degeneration 
changes in the islets of langerhans in all treated groups for four weeks. 
However, histopathological examination of livers showed no evidence of 
degenerative changes in hepatocytes in animals treated with N. sativa for four 
weeks and animals treated with N. sativa + glucose compared to the control group. 
There is a focal infiltration of mononuclear cells especially around blood vessels in 
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group B. There is a focal infiltration of mononuclear cells especially around blood 
vessels, some hepatocytes exhibited fatty degeneration and focal areas of necrosis 
in group E. 
Similarly Al-Daly, 1994 reported that oral administration of N. sativa extract did 
not have a superimposing effect. Focal infiltration of mononuclear cells especially 
around blood vessels in group B it may be due to defensive role against 
degenerative changes in the hepatocytes. Arseculeratna et al., (1981, 1985) have 
previously reported that some plant toxins may damage the hepatic cells at the 
molecular level without causing overt histopathological changes. 
Bouchra et al., 2008 reported that the histological study of kidney, pancreas and 
liver samples after chronic administration of N. sativa aqueous extract over 6 weeks 
showed these tissues to be normal and healthy. This is also consistent with the high 
safety margin observed in rats and mice with N. sativa fixed oil (Zaoui et al., 
2002). 
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CONCLUSIONS 
In the present study it was found that daily oral administration of Nigella sativa 
seeds, supplemented to the basal rat diet, for four weeks resulted in a significant 
reduction in plasma glucose concentration and significant increase insulin level, 
Suggested that this seeds could be used as a hypoglycemic agent to reduced blood 
glucose level. There was no histopathological change in N. sativa treated group but 
there was a significant increase in ALT activity, it may be due to the hepatocytes 
damage at the molecular level. Also the live weight gain, G6PDH activity and 
hemoglobin concentration in treated groups were not affected by dietary treatment 
compared to the control group. 
RECOMMENDATIONS 
There are several lines of research arising from this work which should be pursued.  
• All key enzymes in glucose metabolism should be studied.  
Enzymes of glycolysis eg. hexokinase or glucokinase, phosphofructokinase-
1 and pyruvate kinase that cause decreases in blood glucose concentration.  
Glycogen synthase and glycogen phosphorylase enzymes that decreases and 
increases blood glucose level respectively.   
Gluconeogenesis pathway enzymes eg. glucose-6-phosphatase, fructose-1, 6-
bisphosphatase, phosphoenol pyruvate carboxykinase and pyruvate 
carboxylase which increase blood glucose level. 
• Results provide convincing evidence that intestinal glucose transport 
inhibition represents an important component through which Nigella sativa 
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seeds can reduce blood glucose in this context. Future studies will need to 
elucidate the active principles as well as molecular sites of action responsible 
for the effect of Nigella sativa seed on the intestinal absorption. 
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